Neuromyelitis Optica - 57 Studies Found
Completed |
: Neuromyelitis Optica (NMO) & Cetirizine : Neuromyelitis Optica : 2016-08-09 : Drug: cetirizine Other Name: Zyrtec |
Completed |
: Pilot Study of alpha1-antitrypsin to Treat Neuromyelitis Optica Relapses : Neuromyelitis Optica : 2014-03-11 :
|
Active, not recruiting |
: Autologous Hematopoietic Stem Cell Transplant in Neuromyelitis Optica : Neuromyelitis Optica : 2011-04-18 : Procedure: AHSCT AHSCT Procedure: |
Completed |
: C1-esterase Inhibitor (Cinryze) for Acute Treatment of Neuromyelitis Optica Exacerbation : Neuromyelitis Optica : 2012-12-29 : Drug: C1-esterase inhibitor (Cinryze) Other Name: Cinryze |
Completed |
: Safety and Tolerability of Rituximab in Neuromyelitis Optica : Neuromyelitis Optica : 2007-07-12 : Drug: Rituximab Rituximab is a highly purified, 1328-amino acid antibody with an approximate molecular m |
Completed |
: Phase II Clinical Trial of NPB-01 in Patients With Anti-aquaporin 4 Antibody Positive Neuromyelitis Optica Spectrum Disorder Not Provided Adequate Effect of Therapy to Steroids Plus Therapy. : Neuromyelitis Optica Spectrum Disorder : 2013-04-26 : Drug: NPB-01 Other Name: Intravenous immunoglobulin |
Completed |
: Efficacy and Safety of Mitoxantrone in Patients With Refractory Neuromyelitis Optica and Spectrum Disorders :
|
Completed |
: An Open Label Study of the Effects of Eculizumab in Neuromyelitis Optica :
|
Active, not recruiting |
: Ublituximab for Acute Neuromyelitis Optica (NMO) Relapses :
|
Active, not recruiting |
: Efficacy and Safety of Bortezomib as add-on Treatment in Relapsing Neuromyelitis Optica Spectrum Disorder : Neuromyelitis Optica Spectrum Disorder : 2016-08-27 : Drug: Bortezomib Bortezomib will be subcutaneously applicated in 4 treatment cycles with 4 injections of |